Role of centers with different patient volumes in the management of rhabdomyosarcoma. An analysis by the Italian Pediatric Soft Tissue Sarcoma Committee
Procedure The survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments. Dedicated skills and facilities are indispensable and more readily available at reference centers. In this study, we examined the role of centers’ experi...
Saved in:
Published in | Pediatric blood & cancer Vol. 68; no. 12; pp. e29234 - n/a |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.12.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Procedure
The survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments. Dedicated skills and facilities are indispensable and more readily available at reference centers. In this study, we examined the role of centers’ experience (based on the number of patients treated) in their management of patients with RMS.
Methods
We analyzed 342 patients with localized RMS enrolled in the European RMS 2005 protocol from October 2005 to December 2016 at 31 Italian centers that are part of the Soft Tissue Sarcoma Committee (STSC). We grouped the centers by the number of patients each one enrolled (Group 1: >40; Group 2: <40 and >10; and Group 3: <10), and compared a number of indicators to assess the appropriateness of patients’ diagnostic workup and treatment and their survival.
Results
Overall, 74.6% of patients were treated at 10 centers, and only three of them classifiable as high‐volume centers. Only minor differences emerged between the three patient groups in terms of diagnostic investigations and treatment modalities. Survival was similar in the three groups. Approximately, one in four children treated at the centers in Groups 2 and 3 traveled to another center for surgery or radiotherapy.
Conclusion
Patients treated at STSC centers with different amounts of experience had similar results in terms of survival. This is attributable to all centers in the network adhering to protocol recommendations and receiving the STSC's support on diagnostics and multidisciplinary treatments for RMS. |
---|---|
AbstractList | PROCEDUREThe survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments. Dedicated skills and facilities are indispensable and more readily available at reference centers. In this study, we examined the role of centers' experience (based on the number of patients treated) in their management of patients with RMS. METHODSWe analyzed 342 patients with localized RMS enrolled in the European RMS 2005 protocol from October 2005 to December 2016 at 31 Italian centers that are part of the Soft Tissue Sarcoma Committee (STSC). We grouped the centers by the number of patients each one enrolled (Group 1: >40; Group 2: <40 and >10; and Group 3: <10), and compared a number of indicators to assess the appropriateness of patients' diagnostic workup and treatment and their survival. RESULTSOverall, 74.6% of patients were treated at 10 centers, and only three of them classifiable as high-volume centers. Only minor differences emerged between the three patient groups in terms of diagnostic investigations and treatment modalities. Survival was similar in the three groups. Approximately, one in four children treated at the centers in Groups 2 and 3 traveled to another center for surgery or radiotherapy. CONCLUSIONPatients treated at STSC centers with different amounts of experience had similar results in terms of survival. This is attributable to all centers in the network adhering to protocol recommendations and receiving the STSC's support on diagnostics and multidisciplinary treatments for RMS. The survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments. Dedicated skills and facilities are indispensable and more readily available at reference centers. In this study, we examined the role of centers' experience (based on the number of patients treated) in their management of patients with RMS. We analyzed 342 patients with localized RMS enrolled in the European RMS 2005 protocol from October 2005 to December 2016 at 31 Italian centers that are part of the Soft Tissue Sarcoma Committee (STSC). We grouped the centers by the number of patients each one enrolled (Group 1: >40; Group 2: <40 and >10; and Group 3: <10), and compared a number of indicators to assess the appropriateness of patients' diagnostic workup and treatment and their survival. Overall, 74.6% of patients were treated at 10 centers, and only three of them classifiable as high-volume centers. Only minor differences emerged between the three patient groups in terms of diagnostic investigations and treatment modalities. Survival was similar in the three groups. Approximately, one in four children treated at the centers in Groups 2 and 3 traveled to another center for surgery or radiotherapy. Patients treated at STSC centers with different amounts of experience had similar results in terms of survival. This is attributable to all centers in the network adhering to protocol recommendations and receiving the STSC's support on diagnostics and multidisciplinary treatments for RMS. Abstract Procedure The survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments. Dedicated skills and facilities are indispensable and more readily available at reference centers. In this study, we examined the role of centers’ experience (based on the number of patients treated) in their management of patients with RMS. Methods We analyzed 342 patients with localized RMS enrolled in the European RMS 2005 protocol from October 2005 to December 2016 at 31 Italian centers that are part of the Soft Tissue Sarcoma Committee (STSC). We grouped the centers by the number of patients each one enrolled (Group 1: >40; Group 2: <40 and >10; and Group 3: <10), and compared a number of indicators to assess the appropriateness of patients’ diagnostic workup and treatment and their survival. Results Overall, 74.6% of patients were treated at 10 centers, and only three of them classifiable as high‐volume centers. Only minor differences emerged between the three patient groups in terms of diagnostic investigations and treatment modalities. Survival was similar in the three groups. Approximately, one in four children treated at the centers in Groups 2 and 3 traveled to another center for surgery or radiotherapy. Conclusion Patients treated at STSC centers with different amounts of experience had similar results in terms of survival. This is attributable to all centers in the network adhering to protocol recommendations and receiving the STSC's support on diagnostics and multidisciplinary treatments for RMS. Procedure The survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments. Dedicated skills and facilities are indispensable and more readily available at reference centers. In this study, we examined the role of centers’ experience (based on the number of patients treated) in their management of patients with RMS. Methods We analyzed 342 patients with localized RMS enrolled in the European RMS 2005 protocol from October 2005 to December 2016 at 31 Italian centers that are part of the Soft Tissue Sarcoma Committee (STSC). We grouped the centers by the number of patients each one enrolled (Group 1: >40; Group 2: <40 and >10; and Group 3: <10), and compared a number of indicators to assess the appropriateness of patients’ diagnostic workup and treatment and their survival. Results Overall, 74.6% of patients were treated at 10 centers, and only three of them classifiable as high‐volume centers. Only minor differences emerged between the three patient groups in terms of diagnostic investigations and treatment modalities. Survival was similar in the three groups. Approximately, one in four children treated at the centers in Groups 2 and 3 traveled to another center for surgery or radiotherapy. Conclusion Patients treated at STSC centers with different amounts of experience had similar results in terms of survival. This is attributable to all centers in the network adhering to protocol recommendations and receiving the STSC's support on diagnostics and multidisciplinary treatments for RMS. |
Author | Bisogno, Gianni Affinita, Maria Carmen Ferrari, Andrea Coppadoro, Beatrice Zin, Angelica Milano, Giuseppe Maria De Leonardis, Francesco Manzitti, Carla D'Angelo, Paolo Cataldo, Andrea Di Congiu, Giovanna Cellini, Monica Basso, Eleonora Pericoli, Roberta Alaggio, Rita Melchionda, Fraia Scarzello, Giovanni Zanetti, Ilaria Tamburini, Angela De Corti, Federica Rabusin, Marco |
Author_xml | – sequence: 1 givenname: Gianni orcidid: 0000-0003-4462-5523 surname: Bisogno fullname: Bisogno, Gianni email: gianni.bisogno@unipd.it organization: Padova University Hospital – sequence: 2 givenname: Giovanna surname: Congiu fullname: Congiu, Giovanna organization: Ospedale Microcitemico “A. Cao,” A.O. Brotzu – sequence: 3 givenname: Maria Carmen orcidid: 0000-0003-1680-0240 surname: Affinita fullname: Affinita, Maria Carmen organization: Padova University Hospital – sequence: 4 givenname: Giuseppe Maria orcidid: 0000-0002-0250-6043 surname: Milano fullname: Milano, Giuseppe Maria organization: Ospedale Pediatrico Bambino Gesù, IRCCS – sequence: 5 givenname: Ilaria surname: Zanetti fullname: Zanetti, Ilaria organization: Padova University Hospital – sequence: 6 givenname: Beatrice surname: Coppadoro fullname: Coppadoro, Beatrice organization: Padova University Hospital – sequence: 7 givenname: Carla surname: Manzitti fullname: Manzitti, Carla organization: Giannina Gaslini Children's Hospital – sequence: 8 givenname: Eleonora surname: Basso fullname: Basso, Eleonora organization: Hospital Maggiore della Carità – sequence: 9 givenname: Angela surname: Tamburini fullname: Tamburini, Angela organization: A. Meyer Children's Hospital – sequence: 10 givenname: Fraia orcidid: 0000-0002-6339-8576 surname: Melchionda fullname: Melchionda, Fraia organization: S. Orsola‐University Hospital, IRCCS – sequence: 11 givenname: Monica surname: Cellini fullname: Cellini, Monica organization: Modena University Hospital – sequence: 12 givenname: Roberta surname: Pericoli fullname: Pericoli, Roberta organization: Azienda della Romagna – sequence: 13 givenname: Paolo surname: D'Angelo fullname: D'Angelo, Paolo organization: Di Cristina and Benfratelli – sequence: 14 givenname: Andrea Di orcidid: 0000-0002-4509-3066 surname: Cataldo fullname: Cataldo, Andrea Di organization: Catania University Hospital – sequence: 15 givenname: Francesco orcidid: 0000-0001-5801-7225 surname: De Leonardis fullname: De Leonardis, Francesco organization: Bari University Hospital – sequence: 16 givenname: Marco surname: Rabusin fullname: Rabusin, Marco organization: IRCCS Burlo Garofolo – sequence: 17 givenname: Federica surname: De Corti fullname: De Corti, Federica organization: Padova University Hospital – sequence: 18 givenname: Angelica surname: Zin fullname: Zin, Angelica organization: Padova University Hospital – sequence: 19 givenname: Rita surname: Alaggio fullname: Alaggio, Rita organization: Ospedale Pediatrico Bambino Gesù, IRCCS – sequence: 20 givenname: Giovanni surname: Scarzello fullname: Scarzello, Giovanni organization: Veneto Institute of Oncology, IRCCS – sequence: 21 givenname: Andrea orcidid: 0000-0002-4724-0517 surname: Ferrari fullname: Ferrari, Andrea organization: Fondazione IRCCS Istituto Nazionale Tumori |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34260145$$D View this record in MEDLINE/PubMed |
BookMark | eNp10U9vFCEYBnBiauwfPfgFDIkXPewWGGCYY7ux2qSJjd37hGFeXJphWIGxmW_ixy3bqT2YeOIN_N4nIc8pOhrDCAi9p2RNCWHn-86sWcMq_gqdUMHFShBaH73MpDlGpyndFyqJUG_QccXLRLk4QX9-hAFwsNjAmCEm_ODyDvfOWojlBu91dofzdxgmDwm7EecdYK9H_RP84aXsxp3u-uDnkHQ0wes1vhhxEcOcXMLd_LRynfXg9IhvoXc6R2fwXbAZb11KE-C7ZRNvgvcuZ4C36LXVQ4J3z-cZ2l592W6-rW6-f73eXNysTEUrvuKKAwMmO8KMNKRWlFW05xK0aSzjltAKekX6SlJloVOykZyyWoLSlhhRnaFPS-w-hl8TpNx6lwwMgx4hTKllQlBRN5KoQj_-Q-_DFMsvD0pxXivW1EV9XpSJIaUItt1H53WcW0raQ1ttaat9aqvYD8-JU-ehf5F_6yngfAEPboD5_0nt7eVmiXwENrihBQ |
Cites_doi | 10.1155/2018/3056562 10.1093/annonc/mdz124 10.1634/theoncologist.2018-0121 10.1093/annonc/mdy096 10.1016/j.ejca.2018.12.031 10.1245/s10434-019-07421-9 10.1002/pbc.26348 10.1016/j.ejso.2019.11.518 10.1016/S1470-2045(19)30617-5 10.1016/j.ctrv.2018.06.013 10.1016/S1470-2045(18)30337-1 |
ContentType | Journal Article |
Copyright | 2021 Wiley Periodicals LLC 2021 Wiley Periodicals LLC. |
Copyright_xml | – notice: 2021 Wiley Periodicals LLC – notice: 2021 Wiley Periodicals LLC. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK 7TO 8FD FR3 H94 K9. P64 RC3 7X8 |
DOI | 10.1002/pbc.29234 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Neurosciences Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Genetics Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Genetics Abstracts MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1545-5017 |
EndPage | n/a |
ExternalDocumentID | 10_1002_pbc_29234 34260145 PBC29234 |
Genre | article Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GrantInformation_xml | – fundername: Fondazione Città della Speranza |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1L6 1OC 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABPPZ ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SUPJJ SV3 TEORI UB1 UDS V2E W8V W99 WBKPD WHWMO WIH WIJ WIK WJL WOHZO WQJ WRC WVDHM WXI WXSBR XG1 XV2 ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK 7TO 8FD FR3 H94 K9. P64 RC3 7X8 |
ID | FETCH-LOGICAL-c3134-484e2e26b02c6c0781231d46eac9f24f013ed80d3618feb869641276e8af0c53 |
IEDL.DBID | DR2 |
ISSN | 1545-5009 |
IngestDate | Fri Aug 16 21:54:53 EDT 2024 Thu Oct 10 18:19:20 EDT 2024 Fri Aug 23 02:12:57 EDT 2024 Sat Sep 28 08:20:43 EDT 2024 Sat Aug 24 00:59:30 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | rhabdomyosarcoma centers’ experience multidisciplinary treatment network |
Language | English |
License | 2021 Wiley Periodicals LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3134-484e2e26b02c6c0781231d46eac9f24f013ed80d3618feb869641276e8af0c53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-0250-6043 0000-0001-5801-7225 0000-0002-4509-3066 0000-0003-4462-5523 0000-0002-6339-8576 0000-0002-4724-0517 0000-0003-1680-0240 |
PMID | 34260145 |
PQID | 2584478297 |
PQPubID | 1036357 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2551579608 proquest_journals_2584478297 crossref_primary_10_1002_pbc_29234 pubmed_primary_34260145 wiley_primary_10_1002_pbc_29234_PBC29234 |
PublicationCentury | 2000 |
PublicationDate | December 2021 2021-12-00 20211201 |
PublicationDateYYYYMMDD | 2021-12-01 |
PublicationDate_xml | – month: 12 year: 2021 text: December 2021 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Glenview |
PublicationTitle | Pediatric blood & cancer |
PublicationTitleAlternate | Pediatr Blood Cancer |
PublicationYear | 2021 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2018; 19 2018; 29 2017; 64 2020; 46 2018; 2018 2019; 20 2019; 30 2019; 24 2019; 26 2019; 110 2018; 68 e_1_2_9_11_1 e_1_2_9_10_1 e_1_2_9_9_1 e_1_2_9_12_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 |
References_xml | – volume: 30 start-page: 1143 year: 2019 end-page: 1153 article-title: Surgery in reference centers improves survival of sarcoma patients: a nationwide study publication-title: Ann Oncol – volume: 26 start-page: 2286 year: 2019 end-page: 2293 article-title: Survival benefit of the surgical management of retroperitoneal sarcoma in a reference center: a nationwide study of the French Sarcoma Group from the NetSarc Database publication-title: Ann Surg Oncol – volume: 20 start-page: 1566 year: 2019 end-page: 1575 article-title: Vinorelbine and continuous low‐dose cyclophosphamide as maintenance chemotherapy in patients with high‐risk rhabdomyosarcoma (RMS 2005): a multicentre, open‐label, randomised, phase 3 trial publication-title: Lancet Oncol – volume: 19 start-page: 1061 year: 2018 end-page: 1071 article-title: Addition of dose‐intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open‐label, randomised controlled, phase 3 trial publication-title: Lancet Oncol – volume: 64 year: 2017 article-title: Access to clinical trials for adolescents with soft tissue sarcomas: enrolment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols publication-title: Pediatr Blood Cancer – volume: 68 start-page: 94 year: 2018 end-page: 101 article-title: Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned publication-title: Cancer Treat Rev – volume: 24 start-page: e338 year: 2019 end-page: e346 article-title: Relevance of reference centers in sarcoma care and quality item evaluation: results from the prospective registry of the Spanish Group for Research in Sarcoma (GEIS) publication-title: Oncologist – volume: 29 start-page: iv51 year: 2018 end-page: iv67 article-title: Soft tissue and visceral sarcomas: ESMO‐EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow‐up publication-title: Ann Oncol – volume: 110 start-page: 120 year: 2019 end-page: 126 article-title: Defining and listing very rare cancers of pediatric age: consensus of the Joint Action on Rare Cancers (JARC) in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) publication-title: Eur J Cancer – volume: 2018 year: 2018 article-title: The volume‐outcome relationship in retroperitoneal soft tissue sarcoma: evidence of improved short‐ and long‐term outcomes at high‐volume institutions publication-title: Sarcoma – volume: 46 start-page: 1277 year: 2020 end-page: 1286 article-title: Soft tissue sarcoma in children, adolescents and young adults: outcomes according to compliance with international initial care guidelines publication-title: Eur J Surg Oncol – ident: e_1_2_9_11_1 doi: 10.1155/2018/3056562 – ident: e_1_2_9_4_1 doi: 10.1093/annonc/mdz124 – ident: e_1_2_9_6_1 doi: 10.1634/theoncologist.2018-0121 – ident: e_1_2_9_10_1 doi: 10.1093/annonc/mdy096 – ident: e_1_2_9_2_1 doi: 10.1016/j.ejca.2018.12.031 – ident: e_1_2_9_5_1 doi: 10.1245/s10434-019-07421-9 – ident: e_1_2_9_12_1 doi: 10.1002/pbc.26348 – ident: e_1_2_9_7_1 doi: 10.1016/j.ejso.2019.11.518 – ident: e_1_2_9_9_1 doi: 10.1016/S1470-2045(19)30617-5 – ident: e_1_2_9_3_1 doi: 10.1016/j.ctrv.2018.06.013 – ident: e_1_2_9_8_1 doi: 10.1016/S1470-2045(18)30337-1 |
SSID | ssj0026058 |
Score | 2.376327 |
Snippet | Procedure
The survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments. Dedicated... The survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments. Dedicated skills and... Abstract Procedure The survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments.... ProcedureThe survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments. Dedicated... PROCEDUREThe survival of children with rhabdomyosarcoma (RMS) has gradually improved as a result of the adoption of multidisciplinary treatments. Dedicated... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | e29234 |
SubjectTerms | centers’ experience Child Children Hematology Humans Italy multidisciplinary treatment network Oncology Patients Pediatrics Radiation therapy Rhabdomyosarcoma Rhabdomyosarcoma - surgery Rhabdomyosarcoma, Embryonal Sarcoma Soft Tissue Neoplasms - therapy Soft tissue sarcoma Survival |
Title | Role of centers with different patient volumes in the management of rhabdomyosarcoma. An analysis by the Italian Pediatric Soft Tissue Sarcoma Committee |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpbc.29234 https://www.ncbi.nlm.nih.gov/pubmed/34260145 https://www.proquest.com/docview/2584478297 https://search.proquest.com/docview/2551579608 |
Volume | 68 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VPSAuvB-BggbEgUu2WcdxvOJUKqqCVITaReoBKbIdW61gk6qbPZRfws9lxnmggpAQt0jxyIntmfk8nvkM8CpzdTBayFRrL1LpSrKDpXFpYUwgBx9MbblQ-OijOvwsP5wWp1vwZqyF6fkhpoAba0a016zgxq53f5GGXlg3EwRPmAuUifQYEB1P1FEM02MZHCGEtCAgMbIKZWJ3krzui_4AmNfxanQ4B7fhy_ipfZ7J19mmszP3_TcWx__8lztwawCiuNevnLuw5Zt7cONoOGq_Dz-O228e24CcvkkYETlii-N9Kh0OhKzYm7c1njdIWBJXUzoNy16eGVu3q6t2TfrUrswM9xo0Aw8K2qso8r6LsRacbg3BE_INuIxLAk96SeRKlvOu8_4BLA_eLfcP0-Eah9Tl81ymUksvvFA2E045JhciTFlLRSZ_EYQMHIitdVbnaq6Dt1otlJyLUnltQuaK_CFsN23jHwNaK_IyK52QJpelIdvDu19HiNMtbFB1Ai_H-awuerKOqqdlFhUNcRWHOIGdcaarQV_XlSAcJksuM07gxfSaNI2PT0zj2w23IexX0o5PJ_CoXyFTLzkT_c9lkcDrOM9_77769HY_Pjz596ZP4abgVJqYRbMD293lxj8jLNTZ53HR_wT49gWa |
link.rule.ids | 315,786,790,1382,27955,27956,46327,46751 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEX3o9AgQFx4JJt1nEcr8SlFKotdCvULlIvVWQ7tqjaTapu9lB-CT-XsfNABSEhbpHikRPbM_N5PPMZ4E1iSqck47GUlsXc5GQHc2XiTClHDt6pUvtC4dm-mH7ln46yozV419fCtPwQQ8DNa0aw117BfUB68xdr6Lk2I0b4hF-D66TumVfLDwcDeZQH6qEQjjBCnBGU6HmFErY5iF71Rn9AzKuINbicnTtw3H9sm2lyOlo1emS-_8bj-L9_cxdud1gUt9rFcw_WbHUfbsy60_YH8OOgPrNYO_QZnAQT0Qdtsb9SpcGOkxVbC7fEkwoJTuJiyKjxshfflC7rxWW9JJWqF2qEWxWqjgoF9WUQ2W1CuAWHi0PwkNwDzsOqwMNWEn0xy0nTWPsQ5jsf59vTuLvJITbpOOUxl9wyy4ROmBHG8wsRrCy5IKs_cYw7H4stZVKmYiyd1VJMBB-zXFipXGKy9BGsV3VlnwBqzdI8yQ3jKuW5IvPjN8CGQKeZaCfKCF73E1qct3wdRcvMzAoa4iIMcQQb_VQXncouC0ZQjOe-0jiCV8NrUjZ_gqIqW698G4J_OW36ZASP2yUy9JJ6rv8xzyJ4Gyb6790XX95vh4en_970Jdyczmd7xd7u_udncIv5zJqQVLMB683Fyj4naNToF0EDfgJT2Am6 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVceD8CBQbEgUu2WcdxvOJUWlYt0KpqF6kHpMh2bFG1m6y62UP5Jfxcxs4DFYSEuEWKR05sz8zn8cxngDeJKZ2SjMdSWhZzk5MdzJWJM6UcOXinSu0LhQ8Oxd4X_vE0O12Dd30tTMsPMQTcvGYEe-0VfFG6rV-koQttRozgCb8BN7lImd957R4P3FEep4c6OIIIcUZIoqcVStjWIHrdGf2BMK8D1uBxpnfga_-tbaLJ-WjV6JH5_huN43_-zF243SFR3G6Xzj1Ys9V92DjoztofwI_j-sJi7dDnbxJIRB-yxf5ClQY7RlZs7dsSzyokMInzIZ_Gy15-U7qs51f1khSqnqsRbleoOiIU1FdBZL8JwRYcrg3BE3IOOAtrAk9aSfSlLGdNY-1DmE0_zHb24u4eh9ik45THXHLLLBM6YUYYzy5EoLLkgmz-xDHufCS2lEmZirF0VksxEXzMcmGlconJ0kewXtWVfQKoNUvzJDeMq5TnioyP3_4agpxmop0oI3jdz2exaNk6ipaXmRU0xEUY4gg2-5kuOoVdFoyAGM99nXEEr4bXpGr-_ERVtl75NgT-ctryyQgetytk6CX1TP9jnkXwNszz37svjt7vhIen_970JWwc7U6Lz_uHn57BLebTakJGzSasN5cr-5xwUaNfhPX_EzS5CGk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+centers+with+different+patient+volumes+in+the+management+of+rhabdomyosarcoma.+An+analysis+by+the+Italian+Pediatric+Soft+Tissue+Sarcoma+Committee&rft.jtitle=Pediatric+blood+%26+cancer&rft.au=Bisogno%2C+Gianni&rft.au=Congiu%2C+Giovanna&rft.au=Affinita%2C+Maria+Carmen&rft.au=Milano%2C+Giuseppe+Maria&rft.date=2021-12-01&rft.eissn=1545-5017&rft.volume=68&rft.issue=12&rft.spage=e29234&rft_id=info:doi/10.1002%2Fpbc.29234&rft_id=info%3Apmid%2F34260145&rft.externalDocID=34260145 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1545-5009&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1545-5009&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1545-5009&client=summon |